BM
GILD icon

Bridger Management’s Gilead Sciences GILD Stock Holding History

Bridger Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-921,797
Closed -$65.2M – 36
2017
Q2 		$65.2M Sell
921,797
-103,978
-10% -$6.92M 3.72% 7
2017
Q1 		$69.7M Buy
1,025,775
+314,355
+44% +$22.1M 3.98% 6
2016
Q4 		$50.9M Buy
711,420
+371,969
+110% +$27.6M 3.54% 13
2016
Q3 		$26.9M Buy
+339,451
New +$27.6M 1.81% 23
2014
Q1 		– Sell
-505,000
Closed -$37.9M – 45
2013
Q4 		$37.9M Buy
+505,000
New +$35.2M 2.65% 18

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridger Management's GILD Position: Q3 2017 in Review

Bridger Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 921,797 shares — an estimated $65.2M sold.

Bridger Management first reported a position in GILD in Q4 2013 and held it in 5 quarters. The position peaked at $69.7M in Q1 2017. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Bridger Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Bridger Management sold 921,797 Gilead Sciences shares in Q3 2017, an estimated $65.2M.
  • Bridger Management first reported a position in Gilead Sciences in Q4 2013 and held it in 5 quarters.
  • Bridger Management's Gilead Sciences position peaked at $69.7M in Q1 2017.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Bridger Management's 13F filing for Q3 2017, filed 14 Nov 2017.